Sharlyn Underwood

Critical care RN. Travel addict. Water lover. UCF football junkie.

[Pediatric Nephrology @Ped_Neph]

The selective cytopheretic device for pediatrics (SCD-PED) was granted a Humanitarian Device Exemption in 2024 by the US FDA. Read this Original Article on post-approval experience of the SCD-PED for AKI requiring kidney replacement therapy. #OpenAccess
https://t.co/zkxBid6PV2

[SeaStarMedical @SeaStarMedical]

We’re thrilled to announce that the @US_FDA has granted our Selective Cytopheretic Device (SCD) 2 new Breakthrough Device Designations — bringing our total to 6! This recognition underscores the potential of SCD to address a critical unmet need for patients.

https://t.co/Y7IoKKDSDC

[SeaStarMedical @SeaStarMedical]

The Clinical Training Team is working hard on filming demonstration videos for our customers. #SCD in action! #QUELIMMUNE #ICU $ICU

[Kevin K. Chung, MD @chungk1031]

Our SVP of med affairs and research ⁦@SaiIyerPhD⁩ representing ⁦@SeaStarMedical⁩ at the CKD summit!

#QUELIMMUNE

[Sharlyn Underwood @SeaStarShar]

RT @SeaStarMedical: We’re honored to receive the 2025 Corporate Innovator Award from the @NKF for our #QUELIMMUNE therapy — the first and o…

[SeaStarMedical @SeaStarMedical]

5 organ failures and a 95% chance of death? Sounds like a job for the SCD! Read this new case report from Dr. Humes and team of a pediatric patient with neutropenic septic shock treated with our SCD.

https://t.co/I0HK0OjitI

[Kevin K. Chung, MD @chungk1031]

Selective Cytopheretic Device getting major playing time at #AKICRRT2025!

Thank you @slgold777 for getting this topic in this year’s program.

Shout out to Dr. Humes!

@SeaStarMedical

[Kevin K. Chung, MD @chungk1031]

Our team redid the economic analysis by including LOS data.

Still being peer reviewed but check out the pre-print preview!👇🏼

Great work Nathan Kleinman, Jennifer Kammerer, @slgold777, @SaiIyerPhD, Alec Kleinman, & @CharuThakar!

@SeaStarMedical $ICU

https://t.co/PoKsMg29fE

[Kevin K. Chung, MD @chungk1031]

Welcoming @MayoClinic to #NEUTRALIZEAKI!

@SeaStarMedical

https://t.co/yUqCFmv5Mi

[SeaStarMedical @SeaStarMedical]

A very big day in pediatric AKI, today we announce the FIRST pediatric patient is treated with our QUELIMMUNE therapy!

https://t.co/QJgjJu88RE

[Kevin K. Chung, MD @chungk1031]

Major milestone 👇🏼

Couldn’t ask for a better team to work with. Navigating obstacles, breaking down walls, getting the job done.

Time to get this therapy in critically ill children.

$ICU
#SCDHDEinPEDs
#QUELIMMUNE
@SeaStarMedical

https://t.co/iTCK50uJPp

[Sharlyn Underwood @SeaStarShar]

@CNN It ain’t no lie
Baby D-U-I

[David Catanzaro @PharmDCat]

Proud to be a part of this work!

[Kevin K. Chung, MD @chungk1031]

New device can treat injury from sepsis | Michigan Medicine

#SCDHDEinPeds #QUELimmune
⁦@SeaStarMedical⁩ https://t.co/fkMonhEi7s

[David Catanzaro @PharmDCat]

Cappuccino with Claudio Ronco: 366. Discovery and application of new sel... https://t.co/kLWeMq5rv3 via @YouTube $ICU #SCD @chungk1031 @SaiIyerPhD @slgold777

[SeaStarMedical @SeaStarMedical]

SeaStar is a proud sponsor of the 6th CKD Drug Development Summit, taking place March 19-21 in Boston. The CKD Summit is the premier forum bringing together key opinion leaders, industry partners and regulators focusing on the next generation of drug development in kidney diseases. Our own @chungk1031 will present a plenary session discussing our SCD technology, recent HDE approval in pediatric AKI due to sepsis, and the ongoing NEUTRALIZE-AKI trial in adult AKI #medtwitter #SCD $ICU

[Sharlyn Underwood @SeaStarShar]

Legends.

[David Catanzaro @PharmDCat]

Coming soon…..Cappuccino with Claudio featuring Dr. Humes and @slgold777 discussing our SCD! #CRRT2024 #ICU $ICU

[SeaStarMedical @SeaStarMedical]

Watch the exciting and informative interview from our fearless leader, CEO Eric Schlorff @SchlorffEric as he discusses SeaStar Medical on the Big Biz Show! @sullyontheair @sullyspeaks @biztv @biztalkradio @youtooamerica

[Kevin K. Chung, MD @chungk1031]

Major news from @SeaStarMedical!

Shout out to Dr. David Humes and @slgold777 for your vision.

Thanks to our fearless #CEO @SchlorffEric for navigating our Allstar team through the #MedTech valley of death.

Grateful to $ICU investors for your trust.🙏

Just getting started. 💪

[SeaStarMedical @SeaStarMedical]

PRESS RELEASE: FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

Read the full release HERE: https://t.co/ZJgH6WFWg1

#medicalnews #PressRelease #medicaldevice $ICU